Allergan
- AGN
- NYSE
- Consumer Products
- Latest 97.96
- Currency US$
- Change 0.23
- Percent Change 0.235 %
- Volume 4,355,489
- Thu May 23, 2013 4:00 PM EDT NYSE data delayed 15 minutes.
The Globe and Mail
Earnings & Estimates
Short Term
| Q4/10 | Q1/11 | Q2/11 | Q3/11 | Q4/11 | Q1/12 | Q2/12 | Q3/12 | Q2/13 | Q3/13 | |||
|
Actual quarterly earnings for the past eight quarters and estimated for the next two quarters |
||||||||||||
| Estimated EPS ($) | 0.89 | 0.74 | 0.95 | 0.90 | 1.00 | 0.87 | 1.06 | 1.04 | 1.20 | 1.21 | ||
| Actual EPS | 0.88 | 0.77 | 0.96 | 0.92 | 1.00 | 0.86 | 1.07 | 1.06 | -- | -- | ||
| Surprise (%) | -1.1 | 4.0 | 1.0 | 2.2 | -- | -1.2 | 0.9 | 1.9 | -- | -- | ||
| Est. % Chg from Prior Year | 0.1 | 0.2 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 12.1 | 14.5 | ||
| {#} Analysts | 21 | 22 | 21 | 21 | 23 | 21 | 21 | 23 | 15 | 15 | ||
| Date of Earnings | Feb 02 | May 04 | Aug 03 | Oct 26 | Feb 02 | May 02 | Aug 01 | Oct 30 | Aug 07 | Nov 05 | ||
Data provided by Zacks Investment Research.
Long Term
| 2013 | 2014 | |||
|
Estimated annual earnings for the next |
||||
| Estimated EPS ($) | 4.75 | 5.48 | ||
| Actual EPS | 4.14 | 4.75 | ||
| Surprise (%) | -- | -- | ||
| Est. % Chg from Prior Year | 14.8 | 15.3 | ||
| {#} Analysts | 19 | 18 | ||
| Date of Earnings | -- | -- | ||
Trends & Revisions
Earnings Per Share Trend
| Current | 7-Days Ago | 30-Days Ago | 60-Days Ago | 90-Days Ago | |
| Mean | Mean | Mean | Mean | Mean | |
| Current Quarter (ends Jun 2013) | 1.20 | 1.20 | 1.22 | 1.22 | 1.21 |
| Next Quarter (ends Sep 2013) | 1.21 | 1.21 | 1.20 | 1.19 | 1.18 |
| Current Fiscal Year (ends Dec 2013) | 4.75 | 4.75 | 4.76 | 4.76 | 4.77 |
| Next Fiscal Year (ends Dec 2014) | 5.48 | 5.48 | 5.44 | 5.44 | 5.40 |
Data provided by Zacks Investment Research.
Earnings Revisions
| Last 7 Days | Last 30 Days | |||
| Up Revs | Down Revs | Up Revs | Down Revs | |
| 0 | 0 | 2 | 8 | |
| 0 | 0 | 3 | 3 | |
| 0 | 0 | 5 | 8 | |
| 0 | 0 | 4 | 4 | |